CompletedNCT00142831
Bupropion with nicotine patches and counseling to support smoking cessation
About this title
Read the official source — NCT00142831Medication studyAges 20–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 20 years to 65 years.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- 293
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 20 Years to 65 Years
- Official registry ID
- NCT00142831
- Official title
Show the full official title
Effectiveness of Bupropion Used in Combination With the Nicotine Replacement Patch and Cognitive Behavioral Therapy for Treating Nicotine Dependent Individuals - 1
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Pharmacotherapies for Smoking Cessation.
Who was this study for?
Listed age limits: 20 years to 65 years.
